CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ: CERO · Real-Time Price · USD
8.78
+0.11 (1.27%)
Jul 9, 2025, 10:09 AM - Market open

CERO Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21
31269236223
Market Cap Growth
-95.17%-83.24%-70.89%6.05%-
Enterprise Value
-01470236-
Last Close Price
8.67120.0022000.0020540.6019820.00
PB Ratio
--6.081574.06-21.45-29.01
Debt / Equity Ratio
-4.15-0.8367.45-0.06-
Quick Ratio
0.660.440.430.0211.20
Current Ratio
0.730.500.561.3813.88
Return on Assets (ROA)
-122.86%-178.66%-20.20%-1.63%-
Return on Capital (ROIC)
--758.66%---
Earnings Yield
-425.50%-72.13%-10.61%-0.28%-0.24%
Updated Nov 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q